All times are listed in CEST (Central European Summer Time)
Displaying One Session
Industry Satellite Symposium
Date
22.09.2020
Chairs
- Luis Paz-Ares (Madrid, Spain)
Amgen (Europe) GmbH - New horizons in the era of precision medicine in lung cancer: KRAS and DLL3 as emerging treatment targets
Industry Satellite Symposium
Welcome and introduction (ID 5405)
Speakers
- Luis Paz-Ares (Madrid, Spain)
Amgen (Europe) GmbH - New horizons in the era of precision medicine in lung cancer: KRAS and DLL3 as emerging treatment targets
Industry Satellite Symposium
Emerging biomarkers in NSCLC and SCLC (ID 5406)
Speakers
- Keith M. Kerr (Aberdeen, United Kingdom)
Amgen (Europe) GmbH - New horizons in the era of precision medicine in lung cancer: KRAS and DLL3 as emerging treatment targets
Industry Satellite Symposium
KRAS G12C mutant NSCLC: Current and emerging treatments (ID 5407)
Speakers
- Juergen Wolf (Cologne, Germany)
Amgen (Europe) GmbH - New horizons in the era of precision medicine in lung cancer: KRAS and DLL3 as emerging treatment targets
Industry Satellite Symposium
BiTE: A new way of targeting DLL3 in SCLC (ID 5408)
Speakers
- Luis Paz-Ares (Madrid, Spain)
Amgen (Europe) GmbH - New horizons in the era of precision medicine in lung cancer: KRAS and DLL3 as emerging treatment targets
Industry Satellite Symposium
Future perspectives (ID 5409)
Speakers
- Luis Paz-Ares (Madrid, Spain)
- Juergen Wolf (Cologne, Germany)
- Keith M. Kerr (Aberdeen, United Kingdom)